• Title/Summary/Keyword: Combination therapy

검색결과 1,282건 처리시간 0.024초

A Study on EMG Activation Changes of Spinal Stability Muscles during Forced Respiratory Maneuvers

  • Hong, Soon-Mi;Kweon, Mi-Gyoung;Park, Ji-Won
    • The Journal of Korean Physical Therapy
    • /
    • 제25권3호
    • /
    • pp.143-148
    • /
    • 2013
  • Purpose: The purpose of this study was to investigate whether changes in electromyography (EMG) activations of spinal stability muscles with respiratory demand change were due to changes in respiratory demand or in postural demand. Methods: Forty healthy subjects (19male, 21female, $20.8{\pm}1.9$years old) performed quiet breathing and four different forced respiratory maneuvers (FRM) (Pulsed Lip Breathing, Diaphragmatic Breathing, Combination breathing, and respiratory muscle endurance training breathing) while in sitting and standing positions. EMG data for four muscles (TrA/IO, EO, RA, and ES) were collected and filtered using a band pass filter (20~200Hz) and a notch filter (60, 120, 180Hz). Results: There were no significant differences on percentage of change on %MVIC between QB and FRM (PLB, CB, DB, and RMET) between positions (all p>0.05).

고혈압 치료 지침 Vl에 의한 항고혈압제의 사용평가 (Drug Use Evaluation of Antihypertensive Agents by JNC VI Guidelines)

  • 김경화;이숙향
    • 한국임상약학회지
    • /
    • 제12권1호
    • /
    • pp.29-38
    • /
    • 2002
  • Hypertension is an important public health problem because it increases the risk of stroke, angina, myocardial infarction, heart failure, and end-stage renal disease. If it is not actively treated, morbidity and mortality increase with hypertension-induced complications and quality of life decreases. This study was to evaluate the use of antihypertensive drugs and blood pressure changes and to compare algorithms chosen (or the 1st and 2nd line therapy of hypertension based on the JNC VI recommendations. The medical charts of 222 patients with essential hypertension at St. Vincent's Hospital in Suwon from January 1997 to January 2000 were reviewed retrospectively. Data collection and analysis included baseline BP underlying diseases and complications, administered antihypertensives, BP changes, changes of antihypertensive regimen, and adverse effects with treatments. As results, the higher BP the patients had, the more frequent they had target organ damages and clinical cardiovascular diseases. Mean duration to reduce blood pressure less than 140/90 mmHg was 8 weeks in $85.3\%$ of the patients. The rate of control in BP was $82.4\%$ at 6 months. The major antihypertensive drugs prescribed were calcium channel blockers $(61.8\%)$ , ACE inhibitors $(19.1\%),\;\beta-blockers\;(13.7\%)$ and diuretics $(5.3\%)$ as the 1st-line monotherapy. The methods of treatment used as the 1st-line therapy were monotherapy$(59\%)$ and combination therapy $(41\%)$. Blood pressure change was significantly greater for combination therapy than monotherapy$(-26.2\pm21.4\;vs.\;-18.56\pm16.7$ mmHg for systolic blood pressure; P<0.003, $-16.9\pm13.2\;vs.\;-9.2\pm12.8$ mmHg for diastolic blood pressure; p<0.001). When blood pressure was not completely controlled with the first antihypertensive selected, the 2nd line therapy had 4 options: addition of 2nd agent from different class; $66.2\%$, substitution with another drug, $21.9\%$ increase dose $11.9\%$ continue first regimen $27.9\%$ Calcium channel blockers were the most frequently prescribed agents. This was not comparable to the JNC VI guideline which recommended diuretics and $\beta-blockers$ for the 1st-line therapy. Most of patients achieved the goal BP and maintained it until 6 months, but the remaining patients should be controlled more tightly to improve their BP with combination of life style modification, patient education, and pharmacotherapy.

  • PDF

Protective Effects of Vitamin C on Cisplatin Naphrotoxicity

  • Choung, Se-Young;Kong, Jae-Myeong
    • Archives of Pharmacal Research
    • /
    • 제17권1호
    • /
    • pp.11-16
    • /
    • 1994
  • Cis-dichlorodiammineplatinum(II)(cisplatin) is one of the most effective antitumor agents currently available for cancer therapy. However, its clinical use has been limited by its severe side effects, especially nephrotoxicity. To evaluate the effect or radical scavengers on cisplatin nephrotoxicity in rats, cisplatin and Vitamin C were given intraperitoneally. Remarkable protective effects of Vitamin C against nephrotoxicity of cisplatin were observed when Vitamin C was administered to rats 1hr before cisplatin injection. hepatotoxicity induced by combination treament of cisplatin and Vitamin C was evaluated by measuring serum glutamic pyruvate transmainase(sGPT) and serum glutamic oxalate transminase(sGOT). Combination treatment did not affect the levels of sGPT and sGOT, and any combination treatment did not induce metallothionein biosynthesis in kidny, Vitamin C which has radical scavenging effect induce metallothionein biosynthesis in kidney. Vitamin C which has radical scavenging effect directly reduced nephrotoxicity of cisplatin in vivo. Thus, it seems that free radical is the cause of cisplatin nepthrotoxicity. Also, combination treatment did not reduce anticancer activity of cisplatin. The present results indicate that Vitamin C, when it is given with cisplatin, may provide protection against cisplatin nephrotoxicity without reducing anticancer activity.

  • PDF

Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan

  • Ali, Sajid;Ahmad, Bashir;Ali, Ijaz;Mahmood, Nourin;Anwar, Naveed;Saeedi, Ilyas;Afridi, Jehan Zeb
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권5호
    • /
    • pp.2407-2410
    • /
    • 2016
  • Background: Response to antiviral therapy has been linked to different genotypes and this impacts on clinical management. Data on general responses to standard interferon (IFN) against HCV infection exists but little is known regarding HCV genotype specific responses. Purpose: Therefore, we attempted to determine genotype specific responses of chronic HCV patients, having different HCV genotypes, to standard IFN and ribavirin combination therapy administered for a period of six months in Kybher Pakhtunkhwa province of Pakistan. Materials and Methods: HCV genotype was determined for all serum samples. Each patient received standard IFN combination therapy with ribavirin administered at dose of 3 MIU three times a week and 800-1200 mg/day, respectively, for a period of six months. After completion of this therapy, PCR was performed for all course completed subjects. Results: Out of total 51 selected patients the most abundant genotypes were 3a (49.0%) and 1a (21.6%) followed by 3b (9.8%), 1b (7.84%), 2a (7.84%) and untypable (3.94%). Moast responsive genotypes were 2a followed by 3a, with end of treatment responses of 77.7%, and 72.2%. Responses for 3b, 1b and untypable were 66.7%, 33.3% and 0%, respectively. Conclusions: IFN response is efficient in case of 2a and 3a genotypes while in case of untypable genotypes, further categorization is required to know about genomic sequences and to adopt some new regimes against these genotypes.

Diagnosis and Therapy of Primary Hepatic Neuroendocrine Carcinoma: Clinical Analysis of 10 Cases

  • Wang, Li-Ming;An, Song-Lin;Wu, Jian-Xiong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권6호
    • /
    • pp.2541-2546
    • /
    • 2014
  • Background: Primary hepatic neuroendocrine carcinoma (PHNEC) is rarer than extrahepatic gastrointestinal neuroendocrine carcinoma (NEC). It is difficult to make a correct diagnosis and poses a challenge for management. Materials and Methods: Ten PHNEC patients were admitted to our hospital from June 2006 to June 2011. Laboratory tests and imaging scans were performed for diagnosis and exclusion of extrahepatic NEC. All patients were AFP - and CA199-. Seven patients had solid tumors with cystic changes on ultrasonography, CT and/or MRI. For the initial treatment, four patients received combined-therapy and six monotherapy. Considering overall treatment, six patients received combined-therapy and four patients monotherapy. Staging criteria of primary hepatocellular carcinoma (PHC, AJCC 7th edition) were used to differentiate the stage of all patients: 3 patients were stage I, 2 stageII, 4 patients stageIII and 1 stageIV. All patients were followed up and clinical data were gathered. Results: The median follow-up duration was 38.5 months. The 1-year, 2-year, 3-year and 6-year disease-free survival was 80.0%, 46.2% and 46.2% and 0% respectively. The overall survival rates were 100%, 67.1%, 67.1% and 33.6% respectively. Patients in early-stages (I/II) had similar disease-free and overall survival as those in advanced-stages (III/IV). Patients with monotherapy had significant shorter disease-free and overall survival than the patients with combination-therapy. Conclusions: PHNEC has a unique specificity during its occurrence and development. The staging criteria of PHC might not be suitable for the PHENT. More convenient and effective features need to be found in imaging and laboratory detection. Surgical resection, TACE, chemotherapy and radiofrequency ablation should be performed in combination and actively for patients with PHNEC or recurrence to get the best effectiveness; they might extend the disease-free and overall survival.

항고혈압 약물 3종 복합제에 대한 선진 외국의 임상자료 심사사례 비교 (Comparison of Clinical Development and Evaluation of Triple Antihypertensive Therapy in Advanced Foreign Countries)

  • 왕소영;손수정;엄정윤;임화경;임숙;강승호;이선희
    • 한국임상약학회지
    • /
    • 제23권3호
    • /
    • pp.239-247
    • /
    • 2013
  • Background: Fixed drug combinations are formulations containing two or more active ingredients in a single dosage form. Such combination therapies are commonly applied to improve efficacy, reduce adverse events and replace co-administration, etc. National and international guidelines for hypertension treatment recommend addition of other classes of antihypertensive drugs rather than incremental dose of mono-therapy, when blood pressure is not adequately controlled. Thus, many dual combinations of antihypertensive drugs have been approved and pharmaceutical companies are recently interested in developing antihypertensive triple combinations. Clinical trial designs for the fixed combinations are various depending on the target patients, dosage and clinical endpoints. Thereby, further discussions for the clinical trials of antihypertensive triple therapies are required regarding the indication claimed. Conclusion: This article provides a review for the assessment of the label and medical reports of the clinical trials on antihypertensive triple therapies in advanced foreign countries.

엉덩관절 능동적 신장 운동과 허리 안정화 운동이 궁둥구멍근의 두께와 요통에 미치는 영향 (Effects of active stretching exercise of hip joint and lumbar stabilization exercise on the muscle thickness of piriformis and low back pain)

  • 김치환;박근태;한진태
    • 대한물리치료과학회지
    • /
    • 제28권1호
    • /
    • pp.11-22
    • /
    • 2021
  • Background: This study was to investigate the effects of active stretching and stability exercise on piriformis muscle thickness and low back pain of male patients with chronic low back pain. Design: Randomized Controlled Trial. Methods: 45 male patients participated in this study. All subjects were randomly assigned. Subjects divided into 15 who underwent contract relaxation (CR) of the proprioceptive neuromuscular facilitation (PNF) to their hip joints, 15 who underwent a combination of isotonic (CI) of the PNF, and the rest 15 who underwent the two techniques (CR+CI). Real-time diagnostic ultrasound was used to measure thickness of the piriformis muscles. The visual analogue scale (VAS) was used to measure degrees of low back pain. A two-way repeated measures ANOVA was used to compare the average values. The SPSS 24.0 was used as the statistical program, and the significance level was set at .05. Results: The CR and the CR+CI groups had more decreased thickness of piriformis muscle when compared to the CI group. The CR+CI group had more decreased pain when compared to the CR and the CI groups. Conclusion: These results suggest that combination of stretching and stability exercise was effective on male patients with chronic low back pain showing limited hip medial rotation.

빈도에 따른 복합운동프로그램이 노인들의 체내 총항산능 및 활성산소 유리기에 미치는 영향 (The Analysis of Old Person's Total Antioxidant Capacity and Free Oxygen Radical According to Exercise Frequency of Combination Exercise)

  • 정재민;김은정;윤영조;배성수
    • 대한물리의학회지
    • /
    • 제4권3호
    • /
    • pp.141-148
    • /
    • 2009
  • Purpose:The purpose of this study was analyze the effect combination exercise program on plasma total antioxidant capacity and free oxygen radical according to exercise frequency of elderly. Age range of subject is 65~70 years. Methods:Subjects divided into three groups: control group(0-time), week-3 times group(3-times), week-5 times group(5-times). Each group were performed combination exercise during 8 weeks. Results:The results of each group by ANOVA free oxygen radical have a change(p<.05). We performed comparison of total antioxidant capacity and free oxygen radical pre-test and post-test on each groups. Total antioxidant capacity was increased in the 3-times and 5-times groups but there have not significant. Total antioxidant capacity is improve better than to 5-times. Free oxygen radical is significant increased in the 0-time (p<.05). But 5-times but 3-times is no significant decrease. Free oxygen radical is improve better than to 3-times. Conclusion:In the old people, exercise frequency week 3 times doing appeared effectively in improvement of the free oxygen radical and 5 times doing appeared effectively in improvement of the total antioxidant capacity. So rightly must apply a exercise frequency well in characteristic of old person each person.

  • PDF

Interferon 및 gamma-globulin이 실험적 Pneumocystis carinii 폐염의 치료에 미치는 영향 (Study on the therapeutic effects of interferon and gamma-globulin in experimental Pneumocustis curinii pneumonia)

  • 신대환;강대영
    • Parasites, Hosts and Diseases
    • /
    • 제30권3호
    • /
    • pp.219-226
    • /
    • 1992
  • This study was performed to observe the therapeutic effects of interferon-gamma ($IFN-{\gamma}$) and gamma-globulin (${\gamma}-globulin$) in experimental Pneumocystis carinii pneumonia of immune suppressed mice. After 9 weeks, trimethoprim-sulfamethoxaBole(TMP-SMZ; 10~50 mg/mouse/day), mouse $IFN-{\gamma}(5{\times}10^4$ units/mouse/day) and mouse ${\gamma}-globulin$(20 mg/mouse/day) were administered to the mice for 3 weeks by the experimental group. The therapeutic efficacy was evaluated by body weights, histopatholo단ic and electron microscopic findings of the lungs, and number of p. carinii cysts by Gomori's methenamine silver stain. Body weights of the mice were significantly increased in the group of combination therapy of TMP-SMZ with $IFN-{\gamma}{\;}or{\;}{\gamma}-globulin$, and in the group of TMP- SMZ treatment(p<0.05), however, little effect was found in the group of T-globulin alone. Histopathologic 6ndings of p. carinii pneumonia were much improved in the group of combination therapy of TMP-SMZ with $IFN-{\gamma}$. Treatment with either TMP-SMZ or $IFN-{\gamma}$ significantly reduced the number of cysts in the p. carinii pneumonia, but {\gamma}-globulin alone was ineffective. In electron microscopic findings of p. carinii pneumonia, the number of trophozoites and cysts were reduced by treatment with either TMP-SMZ or $IFN-{\gamma}$, and most of the cysts were empty or containing one or two intracystic bodies. The present results suggested, that combination therapy of TMP-SMZ with $IFN-{\gamma}$ had synergistic effects in treatment of P carinii pneumonia in experi- mental mice.

  • PDF

야뇨증의 진단과 치료에 대한 최신지견 (Diagnosis and treatment of nocturnal enuresis in children)

  • 홍창희;백민기;이성호;이정원;배기수
    • Clinical and Experimental Pediatrics
    • /
    • 제51권11호
    • /
    • pp.1140-1146
    • /
    • 2008
  • Nocturnal enuresis is a heterogeneous disorder with various underlying pathophysiological mechanisms and causes a mismatch between the nocturnal bladder capacity and the amount of urine produced during sleep at night. It is associated with a simultaneous failure of conscious arousal in response to the sensation of bladder fullness. Generally, a complete history and physical examination, with a specific focus on the genitourinary, gastrointestinal, and neurologic systems, is sufficient to evaluate a patient with enuresis. The therapeutic focus is directed toward a differential approach based on the underlying mechanism and toward combination therapies such as alarm devices and desmopressin as well as anticholinergic agents and desmopressin. Children with increased nocturnal urine production usually have a good response to desmopressin therapy. Patients with a small bladder generally show a poor response to desmopressin treatment, but they would benefit more from combination therapy with enuretic alarm, urotherapy, and antimuscarinic agents in addition to desmopressin. Different types of bladder dysfunction, which result in a small nocturnal bladder capacity, probably contribute significantly to the pathogenesis of nocturnal enuresis, particularly in those with treatment failure and refractory symptoms. Because different clinical subgroups may show different responses to treatment, it is necessary to distinguish these subgroups before a decision on the specific treatment protocol can be made.